Baylor Genetics

Excited to be presenting at #SERGG this year! Swing by the Baylor Genetics booth to say hi and learn more about our test offerings.

Genetic conditions are not rare. In our latest genetic myths blog, Billy Mai, Director of Laboratory Operations, explains why. Genetic conditions are often labeled as rare, but they affect an estimated 6-8% of the overall population. From inherited cancers to familial heart conditions and metabolic disorders, our genes play a profound role in shaping our health.    Learn more: www.baylorgenetics.com/ #Genetics 

Individuals with autism spectrum disorder (ASD) often face additional health challenges. A SPARK study of over 42,000 people with ASD, along with a review of nearly 70 studies, found that 74% of individuals with ASD have at least one other medical condition, and about 10% have epilepsy. These findings highlight the value of comprehensive genetic testing, such as Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES). These tests can provide meaningful answers that support quicker, accurate diagnoses, more informed medical care, and better outcomes for your patients. At Baylor Genetics, we are dedicated to helping you find the answers you need. Our WGS and WES incorporate RNA sequencing to help clarify complex genetic variants, and our WGS includes analysis of 29 tandem repeat disorders. Learn more: www.baylorgenetics.com/ #ExomeSequencing #GenomeSequencing

At the NW Rare Disease Fair, our VP of Market Access, Susan Capps, highlighted the expanding role of Whole Genome Sequencing (WGS) in diagnosing rare diseases and emphasized the need to broaden access across three critical settings: hospital care, outpatient services, and newborn screening. We highlighted a Florida bill, now the Sunshine Genetics Act as of last week, which supports adding WGS to standard newborn screening, helping identify genetic conditions earlier. We also spotlighted Washington state’s proposed legislation to reimburse hospitals for Rapid Whole Genome Sequencing outside of the traditional Diagnosis-Related Group payment model. Better access to WGS means faster answers for families. That’s a future we’re working toward at Baylor Genetics. #RareDisease #Genomics #GenomeSequencing

Texans take care of each other. Our hearts are heavy as we witness the devastation caused by flooding across Central Texas. The loss of life — especially so many young lives — is difficult to comprehend. On behalf of everyone at Baylor Genetics, I want to extend our deepest condolences to the families and communities forever changed by this tragedy. As a company based in Houston, we understand the strength it takes to recover — and the importance of standing together during the hardest moments. In support of those impacted, Baylor Genetics has made a contribution to the Texas Children's Hospital’s Central Texas Hope Fund, a trusted initiative providing critical aid to affected families. We also encourage our team, partners, and community to consider contributing. Every act of support — big or small — helps move healing forward. To the first responders, volunteers, and medical professionals working tirelessly — thank you. Your courage reflects the very best of Texas. Learn more and donate here: https://lnkd.in/gmg97Tn3 #FloodRelief #CommunitySupport #TexasStrong

Baylor Genetics is expanding our Revenue Cycle Management team and hiring for two vital roles that help ensure patients receive timely access to care. As an Eligibility Specialist, you'll focus on verifying insurance coverage, resolving claim discrepancies, and ensuring the timely submission of clean, compliant claims. Your precision and problem-solving will play a key role in driving efficient, accurate financial clearance. Apply now: https://bit.ly/4eriSCO We're also seeking a Denials & Appeals Specialist to manage denied claims, prepare and submit appeals, and work closely with payers to resolve complex issues. Your persistence and knowledge of insurance policies will help secure timely reimbursement and reduce delays in care. Click here link to apply for this role: https://bit.ly/4esJO5f #Hiring #RevenueCycle

Florida’s Sunshine Genetics Act is a powerful example of how public policy can help close gaps in care. By adding Whole Genome Sequencing (WGS) to standard newborn screening, Florida is helping identify rare and genetic conditions earlier—often before symptoms appear. For families, that means a chance at earlier answers, timely interventions, and better outcomes. This kind of access isn’t just a clinical milestone—it’s a step toward greater health equity. We’re committed to improving lives by delivering meaningful genetic insights. Supporting policies that expand access to testing is one of the many ways we advance our mission—ensuring more patients and families benefit from the power of precision diagnostics. Learn more: https://lnkd.in/dzhGy_6s #Genomics #HealthEquity #RareDisease #WGS

Behind every rare disease diagnosis is a child, a family, and a story. That’s why we’re celebrating Florida’s Sunshine Genetics Act—a major step forward in bringing Whole Genome Sequencing (WGS) to the very beginning of life. This legislation adds WGS to standard newborn screening for families, helping identify serious conditions before symptoms even appear. For families, this means earlier answers. For children, it means a better chance at timely interventions that can change the course of their health—and their lives. This kind of access doesn’t just expand the reach of precision diagnostics. It brings hope to families searching for clarity, often before they even know there’s a reason to look. At Baylor Genetics, we’re proud to support efforts like these that shorten the diagnostic journey and help improve lives through early, meaningful insights. Learn more: https://lnkd.in/gTKbv-RK #Genomics #Pediatrics #RareDisease #HealthEquity

We asked Laura Fuqua, MS, CGC, Senior Genetic Counselor at Baylor Genetics what affirming care means to her. Laura emphasized that when genetic testing and education reflect the diversity of the people they serve, we foster trust.  Inclusion is essential to delivering effective, compassionate care; at Baylor Genetics, we are committed to ensuring equitable access to genetic testing and resources for all individuals, regardless of their background. Learn how our genetic counselors can help guide you toward informed health decisions: https://lnkd.in/gMBC-2u3 #Inclusivity #GeneticCounseling

Cerebral palsy (CP) is a common motor condition in children, with up to 35% linked to genetic causes. Understanding these genetic factors can help improve care strategies. At Baylor Genetics, we empower healthcare teams with advanced tools like Whole Genome Sequencing (WGS) to navigate CP's complexity. Our comprehensive WGS includes RNAseq, mitochondrial genome analysis, and short tandem repeat expansion testing to uncover hidden pathogenic variants. Explore the impact of WGS on CP diagnosis and clinical decision-making in our latest blog: https://lnkd.in/gZreDsn2 #GenomeSequencing